PI
MIRM icon

Putnam Investments’s Mirum Pharmaceuticals MIRM Stock Holding History

Putnam Investments’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$3.16M Buy
+107,005
New +$3.24M ﹤0.01% 635

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Putnam Investments's MIRM Position: Q4 2023 in Review

Putnam Investments opened a new position in Mirum Pharmaceuticals (MIRM) in Q4 2023: 107,005 shares worth $3.16M. The stake represents ﹤0.01% of the portfolio and ranks #635 among its holdings.

187 funds tracked by Wall St. Rank hold MIRM as of Q4 2023.

  • Putnam Investments held 107,005 shares of Mirum Pharmaceuticals worth $3.16M as of Q4 2023.
  • Mirum Pharmaceuticals was a new Putnam Investments position in Q4 2023.
  • Mirum Pharmaceuticals made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #635 holding.
  • 187 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.